Search results for "Cardiovascular events"
Between-arm differences in systolic blood pressure may indicate increased mortality risk in hypertension
Patients with hypertension who have a between-arm difference of at least 10 mm Hg in systolic blood pressure may be at higher risk for cardiovascular events and death, according to a new study.
https://immattersacp.org/weekly/archives/2012/03/27/4.htm
27 Mar 2012
Beta-blockers didn't benefit stable CAD patients
Taking beta-blockers did not reduce the risk of cardiovascular events for patients with no history or a remote history of myocardial infarction (MI), according to a recent study.
https://immattersacp.org/weekly/archives/2012/10/16/6.htm
16 Oct 2012
Combat cardiac risks of cancer therapies
One challenge of treating cancer is preventing, diagnosing, and treating heart failure in at-risk patients, and figuring out which patients would benefit from intervention.
https://immattersacp.org/archives/2018/09/combat-cardiac-risks-of-cancer-therapies.htm
1 Sep 2018
Chlorthalidone associated with electrolyte abnormalities in older hypertensive patients
Chlorthalidone does not lead to fewer cardiovascular events and deaths than hydrochlorothiazide but may be more likely to cause electrolyte imbalances, especially hypokalemia, according to a new study.
https://immattersacp.org/weekly/archives/2013/03/19/2.htm
19 Mar 2013
Angina not associated with mortality in diabetes patients with coronary artery disease
Patients with type 2 diabetes and stable coronary artery disease had similar risk of cardiovascular events and death, regardless of whether they had angina or angina-like symptoms, a study found.
https://immattersacp.org/weekly/archives/2013/02/12/2.htm
12 Feb 2013
Rosiglitazone restricted to patients who can't take other drugs
Preprocedural statins reduce risk of postprocedure cardiovascular events
https://immattersacp.org/weekly/archives/2010/09/28/4.htm
28 Sep 2010
Nonadherence to antihypertensive medications common in Medicare beneficiaries
Rates of nonadherence varied by patient age, drug class, race and ethnicity, and state of residence.
https://immattersacp.org/weekly/archives/2016/09/20/1.htm
20 Sep 2016
Colonoscopy screening may be less beneficial for average-risk patients ages 75 and older
Screening colonoscopy may provide modest benefit in colorectal cancer prevention among patients ages 70 to 74 years of age but “a smaller (if any) benefit in those who are older,” a study found.
https://immattersacp.org/weekly/archives/2016/09/27/1.htm
27 Sep 2016
Rosuvastatin, atorvastatin compared on effectiveness, safety in industry-funded trial
Analysis of a randomized trial in South Korea found that patients randomized to rosuvastatin developed type 2 diabetes requiring medication at a rate of 7.2%, compared to 5.3% among those given atorvastatin.
https://immattersacp.org/weekly/archives/2023/10/24/4.htm
24 Oct 2023
Telmisartan and valsartan associated with fewer hospital admissions than other ARBs, study finds
In patients with diabetes, telmisartan and valsartan were associated with lower rates of hospitalization for cardiovascular events than other angiotensin-receptor blockers (ARBs), according to a recent retrospective study.
https://immattersacp.org/weekly/archives/2013/07/16/4.htm
16 Jul 2013